In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Immunome Inc (NASDAQ: IMNM) closed at $15.41 in the last session, down -0.26% from day before closing price of $15.45. In other words, the price has decreased by -$0.26 from its previous closing price. On the day, 0.8 million shares were traded. IMNM stock price reached its highest trading level at $15.7 during the session, while it also had its lowest trading level at $14.69.
Ratios:
We take a closer look at IMNM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.18 and its Current Ratio is at 10.18. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.
On April 15, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $35.Guggenheim initiated its Buy rating on April 15, 2024, with a $35 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 21 ’24 when SIEGALL CLAY B bought 20,434 shares for $13.78 per share. The transaction valued at 281,548 led to the insider holds 419,636 shares of the business.
BIENAIME JEAN JACQUES bought 2,000 shares of IMNM for $27,140 on May 21 ’24. The Director now owns 9,615 shares after completing the transaction at $13.57 per share. On May 20 ’24, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 79,566 shares for $13.91 each. As a result, the insider paid 1,106,524 and bolstered with 399,202 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 943272256 and an Enterprise Value of 618438016. For the stock, the TTM Price-to-Sale (P/S) ratio is 72.88 while its Price-to-Book (P/B) ratio in mrq is 3.22. Its current Enterprise Value per Revenue stands at 48.761 whereas that against EBITDA is -14.029.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $6.13. The 50-Day Moving Average of the stock is 10.68%, while the 200-Day Moving Average is calculated to be 3.65%.
Shares Statistics:
According to the various share statistics, IMNM traded on average about 941.23K shares per day over the past 3-months and 638490 shares per day over the past 10 days. A total of 59.97M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 18.31% of the company’s shares, while institutions hold 60.57% stake in the company. Shares short for IMNM as of 1721001600 were 13463058 with a Short Ratio of 14.30, compared to 1718323200 on 8895573. Therefore, it implies a Short% of Shares Outstanding of 13463058 and a Short% of Float of 23.75.
